Standout Papers

HDAC-targeting epigenetic modulators for cancer immunotherapy 2024 202645
  1. HDAC-targeting epigenetic modulators for cancer immunotherapy (2024)
    Binbin Cheng, Yao Xiao et al. European Journal of Medicinal Chemistry

Immediate Impact

1 from Science/Nature 51 standout
Sub-graph 1 of 24

Citing Papers

A covalent peptide-based lysosome-targeting protein degradation platform for cancer immunotherapy
2025 Standout
Advance in peptide-based drug development: delivery platforms, therapeutics and vaccines
2025 Standout
1 intermediate paper

Works of Binbin Cheng being referenced

Discovery of novel cell-penetrating and tumor-targeting peptide-drug conjugate (PDC) for programmable delivery of paclitaxel and cancer treatment
2020
Discovery of novel resorcinol diphenyl ether-based PROTAC-like molecules as dual inhibitors and degraders of PD-L1
2020

Author Peers

Author Last Decade Papers Cites
Binbin Cheng 380 377 170 36 726
Markella Konstantinidou 443 272 93 20 757
Akiko Kume 416 197 229 32 734
Cinzia Borghese 263 446 276 26 823
Stefano Tomassi 485 144 71 42 722
Bernhard Englinger 297 265 67 27 672
Eva‐Laure Matera 347 308 85 32 794
Lijun Zhao 304 388 218 22 785
Yichang Ren 378 276 124 22 668
Annelien J.M. Zweemer 464 264 140 25 745
Guoshun Luo 387 257 58 42 786

All Works

Loading papers...

Rankless by CCL
2026